NR5A2 and colonic neoplasm: Accumulating evidence indicates that LRH‐1 participates in the pathogenesis of multiple tumors including pancreatic (Benod et al., 2011; Petersen et al., 2010), breast (Thiruchelvam et al., 2011), gastric (Wang et al., 2008), and colon cancer (Schoonjans et al., 2005).